體外毒性測試市場規模、佔有率和成長分析：按方法、技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球體外毒性測試市場價值為 137.5 億美元，預計到 2025 年將成長至 152.4 億美元，到 2033 年將成長至 346.1 億美元，在預測期（2026-2033 年）內複合年成長率為 10.8%。

全球體外毒性測試市場的主要驅動力是監管壓力和日益嚴格的安全標準，這些因素鼓勵採用動物試驗的替代方案，從而推動了該領域在整個行業的廣泛應用。該領域涵蓋了細胞檢測、晶片類器官平台和高通量篩檢方法等技術，這些技術能夠以更符合倫理的方式預測化學物質和藥物的毒性，並將結果與人體生物學緊密結合。技術創新正在對市場產生重大影響，提高了預測準確性，縮短了研發週期，並增加了對先進模型的投資。人工智慧透過利用相關檢測數據進行機器學習，實現了自動化分析並提高了安全訊號檢測的準確性，從而推動了這一進步。隨著各組織擴大使用人工智慧驅動的工具，服務供應商的機會也不斷擴大，從而推動了體外毒性測試領域的快速發展。

全球體外毒性測試市場的成長要素

全球體外毒性測試市場正蓬勃發展，這主要得益於監管力度的加大和非動物測試方法的日益普及。這緩解了開發商和買家的擔憂。隨著監管機構制定了明確的驗證路徑，申辦者越來越傾向於採用體外平台，因為他們意識到這可以降低監管風險。這種轉變增加了檢測方法開發商、儀器製造商和服務供應商的需求，最終促進了標準化並推動了更廣泛的商業化。此外，這些趨勢也促進了夥伴關係的建立，從而增強了測試方法的最佳化和擴充性。因此，相關人員正更積極地投資於替代測試技術，進一步推動了檢測方法開發和驗證領域的市場擴張和創新。

全球體外毒性測試市場面臨的限制因素

全球體外毒性測試市場面臨許多挑戰，其中最主要的挑戰在於體外檢測方法的開發和驗證過程繁瑣複雜。這些過程耗時耗力，可能阻礙新方法及時推向市場。建立嚴謹的實驗方案、購置專用設備、遵守監管標準等高昂成本，可能會讓小規模實驗室和新興企業望而卻步。因此，這些經濟負擔阻礙了商業化進程，限制了服務提供者的數量，並抑制了價格競爭。最終，儘管科學不斷進步，但這仍然減緩了成本敏感型產業的普及速度，並限制了整體市場成長。

全球體外毒性測試市場趨勢

全球體外毒性測試市場正經歷著向晶片器官技術的顯著轉變。這些創新平台提供與生理相關的人體組織模型，能夠模擬微環境訊號傳導和細胞間相互作用，加深我們對相關機制的理解，同時減少對動物實驗的依賴。動態流動系統和多細胞共培養方法的應用，使得安全性評估更精準，臨床相關性更高。製藥公司和合約研究組織（CRO）正擴大利用這些先進系統來降低開發平臺中的風險，並簡化候選化合物的篩選流程。隨著這些技術與現有毒理學工作流程的無縫整合，設備製造商、生物學家和CRO之間的合作正在拓展應用領域，規範調查方法，並提高檢測效率。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球體外毒性測試市場規模：依方法分類

• 細胞分析
• 生物化學層級
• In Silico
• 外骨骼
• 其他

全球體外毒性測試市場規模：依技術分類

• 細胞培養
• 高通量篩檢
• 毒理基因組學
• 其他

全球體外毒性測試市場規模：按應用領域分類

• 全身毒性
• 經皮毒性
• 細胞毒性
• 其他

全球體外毒性測試市場規模：依最終用戶分類

• 製藥和生物製藥公司
• 化工
• 食品工業
• 其他

全球體外毒性測試市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• Danaher
• Merck KGaA
• Charles River Laboratories
• SGS
• Eurofins Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• Abbott Laboratories
• Laboratory Corporation of America
• Evotec
• Catalent
• Bio-Techne
• Takara Bio
• Lonza Group
• Promega Corporation
• Genscript Biotech
• Cyprotex
• Intertek Group
• WuXi AppTec

結論與建議

Global In-Vitro Toxicology Testing Market size was valued at USD 13.75 Billion in 2024 and is poised to grow from USD 15.24 Billion in 2025 to USD 34.61 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The global in vitro toxicology testing market is primarily driven by regulatory pressures advocating for alternatives to animal testing and heightened safety standards, prompting widespread industry adoption. This sector encompasses technologies such as cell-based assays, organ-on-chip platforms, and high-throughput screening methods that predict chemical and drug toxicity in a more ethically sound manner, closely aligning results with human biology. Technological innovations significantly impact the market, enhancing predictive accuracy and shortening development timelines while encouraging investment in advanced models. AI contributes to this progress by leveraging machine learning with relevant assay data, facilitating automated analysis and improved safety signal detection. As organizations increasingly utilize AI-driven tools, opportunities expand for service providers, fueling a rapid evolution in the in vitro toxicology landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In-Vitro Toxicology Testing Market Segments Analysis

Global in-vitro toxicology testing market is segmented by method, technology, application, end-user and region. Based on method, the market is segmented into Cellular Assay, Biochemical Hierarchy, In-silico, Ex-vivo and Others. Based on technology, the market is segmented into Cell Culture, High Throughput Screening, Toxicogenomics and Others. Based on application, the market is segmented into Systemic Toxicity, Dermal Toxicity, Cytotoxicity and Others. Based on end-user, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Chemical Industry, Food Industry and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In-Vitro Toxicology Testing Market

The Global In-Vitro Toxicology Testing market is experiencing growth driven by increased regulatory support and acceptance of non-animal testing methods, which alleviates concerns for both developers and purchasers. With clear validation pathways established by agencies, sponsors recognize a decrease in regulatory risk, leading to a heightened focus on adopting in vitro platforms. This shift generates greater demand among assay developers, instrument manufacturers, and service providers, ultimately promoting standardization and facilitating wider commercialization. Additionally, such dynamics encourage partnerships that enhance method optimization and scalability. Stakeholders are thus more inclined to invest in alternative testing technologies, further propelling market expansion and innovation in assay development and validation.

Restraints in the Global In-Vitro Toxicology Testing Market

The Global In-Vitro Toxicology Testing market faces significant challenges due to the extensive development and validation required for in vitro assays. These processes demand considerable time and resources, which can hinder the timely introduction of new methods into the market. The high costs linked to establishing thorough protocols, obtaining specialized instruments, and meeting regulatory standards may discourage smaller labs and emerging companies from engaging in this space. Consequently, such financial burdens can impede commercialization, limit the number of service providers, and suppress competitive pricing. This ultimately delays adoption in cost-sensitive sectors, restricting overall market growth despite ongoing scientific progress.

Market Trends of the Global In-Vitro Toxicology Testing Market

The Global In-Vitro Toxicology Testing market is experiencing a notable shift towards the integration of organ-on-chip technologies. These innovative platforms provide physiologically relevant human tissue models that simulate microenvironmental cues and intercellular interactions, enhancing mechanistic insights while diminishing reliance on animal testing. The adoption of dynamic flow systems and multicellular co-culture approaches allows for more accurate safety assessments and greater translational relevance. Pharmaceutical developers and contract research organizations (CROs) are increasingly leveraging these advanced systems to de-risk development pipelines and streamline candidate selection. Collaborative efforts among device manufacturers, biologists, and CROs are expanding application areas, standardizing methodologies, increasing throughput, and seamlessly integrating these technologies into existing toxicology workflows.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global In-vitro Toxicology Testing Market Size by Method & CAGR (2026-2033)

• Market Overview
• Cellular Assay
• Biochemical Hierarchy
• In-silico
• Ex-vivo
• Others

Global In-vitro Toxicology Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Cell Culture
• High Throughput Screening
• Toxicogenomics
• Others

Global In-vitro Toxicology Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Systemic Toxicity
• Dermal Toxicity
• Cytotoxicity
• Others

Global In-vitro Toxicology Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biopharmaceutical Companies
• Chemical Industry
• Food Industry
• Others

Global In-vitro Toxicology Testing Market Size & CAGR (2026-2033)

• North America (Method, Technology, Application, End-User)
  • US
  • Canada
• Europe (Method, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyprotex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations